CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Prostate cancer is usually treated by reducing the amount of testosterone in the body. PRL-02 depot is a potential treatment for me ...
Phase 1
Jeffersonville, Indiana, United States and 14 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Jeffersonville, Indiana, United States and 131 other locations
the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate...
Phase 1
Jeffersonville, Indiana, United States and 15 other locations
cemiplimab, or in combination with REGN5678. REGN4336, cemiplimab and REGN5678 are a type of treatment for cancer called immunotherapy,and ...
Phase 1, Phase 2
Louisville, Kentucky, United States and 10 other locations
The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate...
Phase 3
Jeffersonville, Indiana, United States and 388 other locations
The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutam...
Phase 2
Jeffersonville, Indiana, United States and 234 other locations
in participants with high-risk, localized or locally advanced prostate cancer receiving primary radiation therapy (RT) results in a...
Phase 3
Jeffersonville, Indiana, United States and 271 other locations
The primary purpose of this study is to determine the pharmacokinetics (PK) and pharmacodynamics (PD) of Debio 4228.
Phase 2
Jeffersonville, Indiana, United States and 22 other locations
A Phase 1 Dose Escalation and Expanded Cohort Study Of PF-06821497 (Mevrometostat) in Adult Patients With Relapsed/Refractory Small Cell Lung Cancer...
Phase 1
Louisville, Kentucky, United States and 100 other locations
assess the safety and efficacy of nivolumab in combination with rucaparib, docetaxel, or enzalutamide in participants with castration-resistant prostate...
Phase 2
Louisville, Kentucky, United States and 65 other locations
Clinical trials
Research sites
Resources
Legal